Patient Savings and Support

We’re Here to Help Your COPD Patients Save on Duaklir® Pressair®

Commerical patients pay no more than $10, even when they have been denied by their commercial plans. E-prescribe DUAKLIR through our local pharmacy network and have DUAKLIR shipped directly to your patients.

E-Prescribe DUAKLIR and Ship Directly to Patients

In addition to retail pharmacies, you can E-prescribe DUAKLIR through a local independent pharmacy within our network, ensuring DUAKLIR is shipped directly to patients within 48 hours—at no extra cost and is guaranteed to always be available.*

  • Hassle-free, cost-effective, and easy to use.
  • Delivered directly to your patients' door at no cost—no waiting in line at the pharmacy!

Use the map to find an independent pharmacy near you:

Use the drop-down list to find an independent pharmacy near you:

*Circassia Pharmaceuticals does not endorse any specific pharmacy. Healthcare professionals may opt to prescribe to any pharmacy. The local independent pharmacy network is currently available in the continental US in select states. 

Independent Pharmacy

-Select a State -

Alabama

Name:
Russellville Drugs

Address: 14001 Highway 43, Ste 13, Russellville, AL 35653

Phone: 2563311919
Fax: (256) 331-1960
NCPDP/NABP: 0140068

Name:
Shoals Pharmacy

Address: 859 E Hobston Street, Tuscumbia, AL 35674

Phone: (256) 389-9800
Fax: (256) 389-1594
NCPDP/NABP: 0138405

Arizona

Name:
Vasco Rx

Address: 4045 E Bell Road, Suite 163, Phoenix, AZ 85032

Phone: (602) 971-6950
Fax: (602) 404-2504
NCPDP/NABP: 0313659

Arkansas

Name:
The Pharmacy at Wellington

Address: 15400 Chenal Parkway, Suite 100, Little Rock, AR 72211

Phone: (501) 708-4320
Fax: (501) 708-4315
NCPDP/NABP: 0425341

California

Name:
Ace Medical Pharmacy

Address: 9171 Wilshire Boulevard, Suite B, Beverly Hills, CA 90210

Phone: (310) 385-9128
Fax: (310) 385-9129
NCPDP/NABP: 5656167

Colorado

Name:
Flatirons Family Pharmacy

Address: 603 Ken Pratt Boulevard, Longmont, CO 80501

Phone: (303) 827-3480
Fax: (303) 827-3540
NCPDP/NABP: 0623276

Connecticut

Name:
Main Street Pharmacy (MSP)

Address: 2117 Boston Avenue, Bridgeport, CT 06610

Phone: (203) 212-3800
Fax: (203) 212-3802
NCPDP/NABP: 0722327

Delaware

Name:
Greenhill Pharmacy

Address: 2500 W 4th Street, Suite 1, Wilmington, DE 19805

Phone: (302) 660-8847
Fax: (302) 502-3885
NCPDP/NABP: 0845733

District of Columbia

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Florida

Name:
Ricker Pharmacy

Address: 7628 103rd Street, Suite 5, Jacksonville, FL 32210

Phone: (904) 900-3500
Fax: (904) 900-3505
NCPDP/NABP: 5709425

Name:
Acquaviva Pharmacy

Address: 1555 Port Malabarb Boulevard, Palm Bay, FL 32905

Phone: (321) 725-7188
Fax: (321) 728-1333
NCPDP/NABP: 1038036

Name:
Specialty Care Pharmacy

Address: 4802 NW 2nd Avenue, Boca Raton, FL 33431

Phone: (561) 241-7711
Fax: (561) 241-7717
NCPDP/NABP: 5717585

Georgia

Name:
Bainbridge Pharmacy

Address: 1420 E Evans Street, Bainbridge, GA 39819

Phone: (229) 246-7200
Fax: (229) 246-6210
NCPDP/NABP: 1106586

Name:
Richmond Hill Pharmacy

Address: 2409 Highway 17, Richmond Hill, GA 31324

Phone: (912) 756-3331
Fax: (912) 756-5904
NCPDP/NABP: 1123683

Name:
West End Pharmacy

Address: 824 West Avenue, Carterville, GA 30120

Phone: (770) 606-0697
Fax: (770) 606-0695
NCPDP/NABP: 1159640

Idaho

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Illinois

Name:
Local Healthmart Pharmacy

Address: 2545 W Diversey Ave, Ste 104, Chicago, IL 60647

Phone: (773) 673-5493
Fax: (844) 270-4705
NCPDP/NABP: 1492331

Indiana

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Iowa

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Kansas

Name:
Dandurand Drugs

Address: 800 N Carriage Pkwy, Wichita, KS 67208

Phone: (316) 858-5890
Fax: (316) 858-5899
NCPDP/NABP: 1719484

Kentucky

Name:
Save-Rite Drugs

Address: 14020 E Highway 60, Irvington, KY 40146

Phone: (270) 547-2855
Fax: (270) 547-2857
NCPDP/NABP: 1805502

Louisiana

Name:
Majoria Drugs - Terrytown

Address: 888 Terry Parkway, Terrytown, LA 70056

Phone: (504) 392-1551
Fax: (504) 392-9213
NCPDP/NABP: 1924415

Name:
Walker Pharmacy

Address: 29811 Walker South Rd, Walker, LA 70785

Phone: (225) 243-4852
Fax: (225) 243-7983
NCPDP/NABP: 1936826

Maine

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Maryland

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Massachusetts

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Michigan

Name:
MedCenter

Address: 7210 N Main Street, Suite 102, Clarkston, MI 48346

Phone: (248) 625-3885
Fax: (248) 625-3886
NCPDP/NABP: 2366741

Minnesota

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Mississippi

Name:
Saltillo Pharmacy & Solutions

Address: 2698 Highway 145, Saltillo, MS 38866

Phone: (662) 269-2781
Fax: (662) 269-2037
NCPDP/NABP: 2588296

Missouri

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Montana

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Nebraska

Name:
Via Rx

Address: 825 N 90th Street, Omaha, NE 68114

Phone: (402) 614-6363
Fax: (402) 505-4397
NCPDP/NABP: 2818687

Nevada

Name:
986 Specialty Pharmacy #2

Address: 241 N Buffalo Dr, Ste 150, Las Vegas, NV 89145

Phone:
Fax:
NCPDP/NABP: 2994817

New Hampshire

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

New Jersey

Name:
Silverton Pharmacy

Address: 1824 Hooper Avenue, Toms River, NJ 08753

Phone: (732) 255-4788
Fax: (732) 255-1816
NCPDP/NABP: 3101425

Name:
White Oak Pharmacy

Address: 88 Union Ave, Nutley, NJ 07110

Phone: (888) 281-1434
Fax: (888) 853-5826
NCPDP/NABP: 3102655

New Mexico

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

New York

Name:
Ahma Rx

Address: 2381 Fredrick Douglass Boulevard, New York City, NY 10027

Phone: (212) 749-6626
Fax: (212) 749-6629
NCPDP/NABP: 5807738

Name:
Attica Pharmacy

Address: 2 Market Street, Attica, NY 14011

Phone: (585) 591-1111
Fax: (585) 591-1112
NCPDP/NABP: 5818022

Name:
Westriver Pharmacy

Address: 66 Main Street, Yonkers, NY 10701

Phone: (914) 457-3351
Fax: (888) 457-9332
NCPDP/NABP: 5825192

North Carolina

Name:
Realo Specialty Care

Address: 130 Pine Street, Suite C, Lillington, NC 27546

Phone: (910) 814-1943
Fax: (910) 814-1909
NCPDP/NABP: 3464776

Name:
Eden Drug Healthmart

Address: 103 W Stadium Drive, Eden, NC 27288

Phone: (336) 627-4854
Fax: (336) 627-8925
NCPDP/NABP: 3420015

North Dakota

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Ohio

Name:
MAC Pharmacy

Address: 1 Park W Boulevard, Suite 140, Akron, OH 44320

Phone: (330) 556-4515
Fax: (330) 556-4516
NCPDP/NABP: 3685611

Name:
Monroe Pharmacy

Address: 4122 Monroe Street, Toledo, OH 43606

Phone: (419) 842-1531
Fax: (419) 472-1146
NCPDP/NABP: 3608392

Oklahoma

Name:
Asbury Pharmacy

Address: 3401 N May Avenue, Suite B, Oklahoma City, OK 73112

Phone: (405) 843-6691
Fax: (405) 848-3591
NCPDP/NABP: 3715820

Oregon

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Pennsylvania

Name:
Reliant Care Solutions

Address: 403 S Oxford Valley Road, Suite 2, Fairless Hills, PA 19030

Phone: (215) 547-1700
Fax: (215) 547-1722
NCPDP/NABP: 6000602

Name:
East Norriton Pharmacy

Address: 215 W Germantown Pike, East Norriton, PA 19401

Phone: (484) 370-1111
Fax: (484) 751-5245
NCPDP/NABP: 6006197

Name:
Heritage Therapeutics

Address: 2173 MacDade Blvd, Holmes, PA 19043

Phone: (855) 343-2136
Fax: (855) 658-2707
NCPDP/NABP: 3999488

Name:
Marple Pharmacy

Address: 2530 W Chester Pike, Broomall, PA 19008

Phone: (610) 356-6491
Fax: (610) 356-6492
NCPDP/NABP: 6005690

Rhode Island

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

South Carolina

Name:
Tidewater Pharmacy

Address: 421 Johnnie Dodds Boulevard, Ste 100, Mount Pleasant, SC 29464

Phone: (843) 375-6310
Fax: (843) 375-6311
NCPDP/NABP: 4233057

South Dakota

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Tennessee

Name:
Munford Pharmacy

Address: 99 Doctors Drive, Suite 100, Munford, TN 38058

Phone: (901) 840-4400
Fax: (901) 840-1975
NCPDP/NABP: 4442911

Name:
Riverside Village Pharmacy

Address: 1406 McGavock Pike, Suite A, Nashville, TN 37216

Phone: (615) 650-4444
Fax: (615) 650-6828
NCPDP/NABP: 4444496

Name:
Medicine Shoppe of Knoxville

Address: 4206 Chapman Highway, Knoxville, TN 37920

Phone: (865) 579-4547
Fax: (865) 579-0030
NCPDP/NABP: 4427111

Texas

Name:
Manor Pharmacy

Address: 14008 Shadow Glen Boulevard, Suite 102, Manor, TX 78653

Phone: (512) 642-8000
Fax: (512) 642-8001
NCPDP/NABP: 5916258

Name:
Biocare Pharmacy

Address: 10603 Bellaire Boulevard, Suite B114, Houston, TX 77072

Phone: (281) 530-5800
Fax: (281) 530-5819
NCPDP/NABP: 4545060

Name:
15Rx Pharmacy 1

Address: 418 Carson Hill Drive, San Antonio, TX 78251

Phone: (210) 684-1579
Fax: (210) 684-1581
NCPDP/NABP: 5902312

Utah

Name:
A&W Pharmacy

Address: 171 E Main Street, Duchesne, UT 84021

Phone: (435) 738-3784
Fax: (435) 738-3785
NCPDP/NABP: 4612950

Vermont

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Virginia

Name:
Joule Wellness Pharmacy

Address: 1028 S Walter Reed Drive, Arlington, VA 22204

Phone: (571) 699-3593
Fax: (855) 382-7706
NCPDP/NABP: 4845282

Washington

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

West Virginia

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Wisconsin

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

Wyoming

Call Circassia Connect to find an independent pharmacy near you.
(844) 892-7872

DUAKLIR $10 Commercial Guarantee

The DUAKLIR Commercial Guarantee ensures eligible, commercially insured patients pay no more than $10—even commercially rejected patients.

DUAKLIR Savings Card Coupon

If, for any reason, patients pay more than $10, simply call:

1-844-892-7872

Dedicated line staffed by pharmacy-level technicians  this is not an automated service.

See commercial eligibility rules for this Savings Card offer; restrictions apply.

Indication and Usage

DUAKLIR PRESSAIR (aclidinium bromide/formoterol fumarate inhalation powder) is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Important Safety Information

  • DUAKLIR PRESSAIR (aclidinium bromide/formoterol fumarate inhalation powder) is only indicated for use in COPD and is not indicated for use in asthma. Use of a long-acting beta2-adrenergic agonist (LABA) as monotherapy, including formoterol fumarate, one of the active ingredients in DUAKLIR PRESSAIR, without an inhaled corticosteroid (ICS) is contraindicated in patients with asthma and increases the risk of asthma-related death. When LABA are used in fixed-dose combinations with ICS, data from large clinical trials do not show a significant increase in the risk of serious asthma-related events (hospitalizations, intubations, death) compared to ICS alone.
  • DUAKLIR PRESSAIR is contraindicated in patients with severe hypersensitivity to milk proteins or who have hypersensitivity to aclidinium bromide or formoterol fumarate or any component of the product
  • DUAKLIR PRESSAIR is not indicated for the treatment of acute episodes of bronchospasm (i.e. rescue therapy)
  • Do not initiate DUAKLIR PRESSAIR with an additional medicine containing a LABA because of risk of overdose or in acutely deteriorating COPD
  • Immediate hypersensitivity reactions, including anaphylaxis, angioedema (swelling of lips, tongue, or throat), urticaria, rash, bronchospasm, or itching have occurred after administration of DUAKLIR PRESSAIR. Additionally, inhaled medicines, including DUAKLIR PRESSAIR, may cause paradoxical bronchospasm which may be life threatening. If any of these occurs, immediate treatment with a short acting bronchodilator should be initiated and treatment with DUAKLIR PRESSAIR should be stopped and alternative therapy initiated
  • DUAKLIR PRESSAIR should be used with caution in patients with cardiovascular and convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, narrow-angle glaucoma or urinary retention. Instruct patients to consult a physician immediately should any signs or symptoms of acute narrow-angle glaucoma or prostatic hyperplasia or bladder-neck obstruction develop
  • The most common adverse reactions (≥3% incidence and more common than placebo) were upper respiratory tract infection (8.9% vs 6.3%), headache (6.3% vs 5.1%), and back pain (3.8% vs 3.4%) for DUAKLIR PRESSAIR vs placebo, respectively. Other adverse reactions reported in clinical studies (>1% but less than 3% and more common than placebo) with DUAKLIR PRESSAIR were cough, sinusitis, influenza, tooth abscess, insomnia, dizziness, dry mouth, oropharyngeal pain, muscle spasm, musculoskeletal pain, arthralgia, pain in extremity, urinary tract infection, and increased blood creatine phosphokinase

Medical Information

For answers to your medical questions about DUAKLIR PRESSAIR, please contact Circassia Medical Information at medinfo.us@circassia.com.

Please also see the full Prescribing Information, including Patient Information.

  • DUAKLIR PRESSAIR (aclidinium bromide/formoterol fumarate inhalation powder) is only indicated for use in COPD and is not indicated for use in asthma. Use of a long-acting beta2-adrenergic agonist (LABA) as monotherapy, including formoterol fumarate,
  • DUAKLIR PRESSAIR (aclidinium bromide/formoterol fumarate inhalation powder) is only indicated for use in COPD and is not indicated for use in asthma. Use of a long-acting beta2-adrenergic agonist (LABA) as

Indication and Usage

DUAKLIR PRESSAIR (aclidinium bromide/formoterol fumarate inhalation powder) is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Important Safety Information

  • DUAKLIR PRESSAIR (aclidinium bromide/formoterol fumarate inhalation powder) is only indicated for use in COPD and is not indicated for use in asthma. Use of a long-acting beta2-adrenergic agonist (LABA) as monotherapy, including formoterol fumarate, one of the active ingredients in DUAKLIR PRESSAIR, without an inhaled corticosteroid (ICS) is contraindicated in patients with asthma and increases the risk of asthma-related death. When LABA are used in fixed-dose combinations with ICS, data from large clinical trials do not show a significant increase in the risk of serious asthma-related events (hospitalizations, intubations, death) compared to ICS alone.
  • DUAKLIR PRESSAIR is contraindicated in patients with severe hypersensitivity to milk proteins or who have hypersensitivity to aclidinium bromide or formoterol fumarate or any component of the product
  • DUAKLIR PRESSAIR is not indicated for the treatment of acute episodes of bronchospasm (i.e. rescue therapy)
  • Do not initiate DUAKLIR PRESSAIR with an additional medicine containing a LABA because of risk of overdose or in acutely deteriorating COPD
  • Immediate hypersensitivity reactions, including anaphylaxis, angioedema (swelling of lips, tongue, or throat), urticaria, rash, bronchospasm, or itching have occurred after administration of DUAKLIR PRESSAIR. Additionally, inhaled medicines, including DUAKLIR PRESSAIR, may cause paradoxical bronchospasm which may be life threatening. If any of these occurs, immediate treatment with a short acting bronchodilator should be initiated and treatment with DUAKLIR PRESSAIR should be stopped and alternative therapy initiated
  • DUAKLIR PRESSAIR should be used with caution in patients with cardiovascular and convulsive disorders, thyrotoxicosis, diabetes mellitus, ketoacidosis, hypokalemia, hyperglycemia, narrow-angle glaucoma or urinary retention. Instruct patients to consult a physician immediately should any signs or symptoms of acute narrow-angle glaucoma or prostatic hyperplasia or bladder-neck obstruction develop
  • The most common adverse reactions (≥3% incidence and more common than placebo) were upper respiratory tract infection (8.9% vs 6.3%), headache (6.3% vs 5.1%), and back pain (3.8% vs 3.4%) for DUAKLIR PRESSAIR vs placebo, respectively. Other adverse reactions reported in clinical studies (>1% but less than 3% and more common than placebo) with DUAKLIR PRESSAIR were cough, sinusitis, influenza, tooth abscess, insomnia, dizziness, dry mouth, oropharyngeal pain, muscle spasm, musculoskeletal pain, arthralgia, pain in extremity, urinary tract infection, and increased blood creatine phosphokinase

Medical Information

For answers to your medical questions about DUAKLIR PRESSAIR, please contact Circassia Medical Information at medinfo.us@circassia.com.

Please also see the full Prescribing Information, including Patient Information.

REFERENCES: 1. Loveridge B, et al. Am Rev Respir Dis. 1986;134(5):930-934. 2. Duaklir® Pressair® (aclidinium bromide/formoterol fumarate inhalation powder)[prescribing information]. Morrisville, NC: Circassia Pharmaceuticals Inc; 2019. 3. Sethi S, et al. International Journal of COPD. 2019;14:667-682. 4. Data on file, Circassia. 5. Jones PW, et al. Respir Med. 1991;85(suppl B):25-31. 6. D'Urzo AD, et al. Respir Res. 2014;15:123. 7. Miravitlles M, et al. Respir Res. 2014;15:122. 8. Balachandran J, et al. Am J Respir Grit Care Med. 2013;188:5-6. 9. Singh D, et al. BMC Pulmonary Medicine. 10. Cote CG, et al. Chest. 2008;134:104001. 11. Wise RA, et al. JAMA. 2019;321(17):1693-1701. 12. Tudorza® Pressair® (aclidinium bromide inhalation powder) [prescribing information]. Morrisville, NC: Circassia Pharmaceuticals Inc; 2019. 13. Ocakli B, et al. Int J Chron Obstruct Pulmon Dis. 2018;13:2941-2947. 14. Centers for Disease Control and Prevention. Chronic Obstructive Pulmonary Disease Among Adults – United States, 2011. MMWR. Nov 2012;61(46);938-943. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6146a2.htm?s_cid=mm6146a2_w. Accessed April 7, 2016. 15. Centers for Disease Control and Prevention. Deaths: Leading Causes for 2017. National Vital Statistics Reports. 2019;68(6). https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_06-508.pdf. Published June 24, 2019. Accessed August 19, 2019. 16. National Heart, Lung, and Blood Institute (NHLBI). Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases. http://www.nhlbi.nih.gov/files/docs/research/2012_ChartBook_508.pdf. Published February 2012. Accessed April 7, 2016. 17. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Updated November 2018. Accessed July 16, 2019. 18. Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD Surveillance–United States, 1999-2011. Chest. 2013;144(1):284-305. 19. Chronic Obstructive Pulmonary Disease (COPD) Includes: Chronic Bronchitis and Emphysema. National Center for Health Statistics website. https://www.cdc.gov/nchs/fastats/copd.htm. Updated May 3, 2017. Accessed July 16, 2019. 20. American Lung Association. What Causes COPD. http://www.lung.org/lung-health-and-diseases/lung-disease-lookup/copd/symptoms-causes-risk-factors/what-causes-copd.html. Published 2016. Accessed April 7, 2016. 21. World Health Organization. Causes of COPD. http://www.who.int/respiratory/copd/causes/en/#. Accessed April 7, 2016.